Cargando...
Fulvestrant for hormone‐sensitive metastatic breast cancer
BACKGROUND: Fulvestrant is a selective oestrogen receptor down‐regulator (SERD), which by blocking proliferation of breast cancer cells, is an effective endocrine treatment for women with hormone‐sensitive advanced breast cancer. The goal of such systemic therapy in this setting is to reduce symptom...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2017
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464820/ https://ncbi.nlm.nih.gov/pubmed/28043088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011093.pub2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|